Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9
- DOI
- 10.1016/j.omtm.2021.01.001
- Published
- 2021-03
- Container
- Molecular Therapy - Methods & Clinical Development
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtm.2021.01.001,
title = {Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9},
author = {Suvd Byambaa and Hideki Uosaki and Tsukasa Ohmori and Hiromasa Hara and Hitoshi Endo and Osamu Nureki and Yutaka Hanazono},
year = {2021},
journal = {Molecular Therapy - Methods \& Clinical Development},
doi = {10.1016/j.omtm.2021.01.001},
url = {https://doi.org/10.1016/j.omtm.2021.01.001}
}RIS
TY - JOUR TI - Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9 AU - Suvd Byambaa AU - Hideki Uosaki AU - Tsukasa Ohmori AU - Hiromasa Hara AU - Hitoshi Endo AU - Osamu Nureki AU - Yutaka Hanazono PY - 2021 JO - Molecular Therapy - Methods & Clinical Development DO - 10.1016/j.omtm.2021.01.001 UR - https://doi.org/10.1016/j.omtm.2021.01.001 ER -
APA
Byambaa, S., Uosaki, H., Ohmori, T., Hara, H., Endo, H., Nureki, O., & Hanazono, Y. (2021). Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9. Molecular Therapy - Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2021.01.001
Source records
- crossref · retrieved 2026-09-25T06:09:24.038Z